Day One Biopharmaceuticals
DAWN
6,13 €
Share price
-1.80%
Change (1 day)
-56.85%
Change (1 year)
Categories
Day One Biopharmaceuticals (DAWN) - P/B ratio
P/B ratio as of July 2025 : 1.50
According to Day One Biopharmaceuticals's latest financial reports the company has a price-to-book ratio of 4.44455.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Day One Biopharmaceuticals - P/B ratio (from 2021 to 2025)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2025-12-31 | N/A | -100% |
| 2024-12-31 | 2.58 | -29.6% |
| 2023-12-31 | 3.67 | -23.07% |
| 2022-12-31 | 4.77 | 28.43% |
| 2021-12-31 | 3.71 | |
| 2020-12-31 | N/A |